Thomas J. Henry Injury Attorneys Representing 19 Victims and Investigating 4 Deaths in Individuals Potentially Exposed to Recalled IV drugs from Specialty Compounding LLC

Share Article

Thomas J. Henry Injury Attorneys has filed a Temporary Restraining Order against Specialty Compounding, LLC in order to preserve all evidence pertinent to the IV infection cases.

News Image

Thomas J. Henry

“We want to ensure that we have all the facts we need to piece together when, how, and why these tainted drugs got distributed to our local hospitals,” Thomas J. Henry.

Thomas J. Henry Injury Attorneys is investigating 4 deaths in individuals who may have been exposed to tainted IV drugs at Corpus Christi Medical Center Bay Area and Corpus Christi Medical Center Doctors Regional hospitals (1). The firm is currently representing 19 individuals relative to this matter.

The tainted medications were recalled by Specialty Compounding, LLC on August 9, 2013 (1).

According to the Voluntary Recall Notice issued by Specialty Compounding, LLC, “Recalled products were distributed directly to hospitals and physician offices in Texas. Recalled products were also sent directly to individuals located nationwide with the exception of North Carolina.”

--Piecing Together a Timeline--

On August 14, 2013, Thomas J. Henry Injury Attorneys filed a Temporary Restraining Order (TRO) (Cause No. 2013-CCV-61504-2, Nueces County Court at Law No. 2) against Specialty Compounding, LLC in order to preserve all evidence pertinent to the IV infection cases. On August 16, 2013, the firm filed a second TRO (Cause No. 2013-CCV-61520-2, Nueces County Court at Law No. 2) to protect evidence pertaining to new potential victims.

“These TROs are essential in ensuring Specialty Compounding, LLC does not destroy or alter any evidence which may aid in the ongoing investigation,” lead attorney, Thomas J. Henry said, adding that the evidence is essential in piecing together a timeline. “We are trying to find out who knew what, and when they knew it.”

--Thomas J. Henry Issues Statement Regarding IV Infection Cases--

Thomas J. Henry Injury Attorneys are working diligently to determine how and why these events occurred and how they could have been prevented.

“We want to ensure that we have all the facts we need to piece together when, how, and why these tainted drugs got distributed to our local hospitals,” Thomas J. Henry stated.

Specifically, the firm is investigating whether or not the hospitals in question had access to the FDA 483 report and whether or not Specialty Compounding, LLC had a duty to report these findings to the health care facilities that purchase their medications. Thomas J. Henry issued the following statement regarding the matter:

“If these hospitals or Specialty Compounding, LLC knew or should have known people were becoming ill associated with calcium gluconate and they delayed in notifying the public, this would be a complete disregard for patient safety. It is essential that we get to the bottom of this.

We need to protect any information that may help determine the cause of these events and we need to get these injured individuals the answers they deserve.

All government agencies need to quickly and accurately investigate this matter so to resolve issues regarding the nature, extent, duration and scope of exposure to tainted products distributed and placed into patients. Additional government oversight of compounding, distribution, and quality assurance needs to be addressed to safeguard patients,” Thomas J. Henry.

--Contact Thomas J. Henry Injury Attorneys--

Thomas J. Henry Injury Attorneys are currently investigating cases of serious bacterial infections at Doctor’s Regional and Bay Area hospitals in Corpus Christi, Texas. If you contracted a bacterial infection during a stay at a Corpus Christi Medical Center facility, contact our offices immediately. We are available 24/7 nights and weekends.

(1) FDA, August 11, 2013; http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm364644.htm
(2) FDA, March 23, 2013; http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM345935.pdf

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Thomas J. Henry Injury Attorneys
(888) 956-8000
Email >
Visit website

Media